12 01/04/2023 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 05039242 2023-04-01 2024-03-31 05039242 2024-03-31 05039242 2023-03-31 05039242 2022-04-01 2023-03-31 05039242 2023-03-31 05039242 2022-03-31 05039242 bus:RegisteredOffice 2023-04-01 2024-03-31 05039242 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 05039242 bus:Director1 2023-04-01 2024-03-31 05039242 bus:Director2 2023-04-01 2024-03-31 05039242 bus:CompanySecretary1 2023-04-01 2024-03-31 05039242 core:RetainedEarningsAccumulatedLosses 2022-04-01 2023-03-31 05039242 core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 05039242 core:WithinOneYear 2024-03-31 05039242 core:WithinOneYear 2023-03-31 05039242 core:AfterOneYear 2024-03-31 05039242 core:AfterOneYear 2023-03-31 05039242 core:ShareCapital 2024-03-31 05039242 core:ShareCapital 2023-03-31 05039242 core:RetainedEarningsAccumulatedLosses 2024-03-31 05039242 core:RetainedEarningsAccumulatedLosses 2023-03-31 05039242 core:PreviouslyStatedAmount core:ShareCapital 2022-03-31 05039242 core:PreviouslyStatedAmount core:RetainedEarningsAccumulatedLosses 2022-03-31 05039242 core:PreviouslyStatedAmount 2022-03-31 05039242 core:ShareCapital 2022-03-31 05039242 core:RetainedEarningsAccumulatedLosses 2022-03-31 05039242 core:PreviouslyStatedAmount core:ShareCapital 2023-03-31 05039242 core:PreviouslyStatedAmount core:RetainedEarningsAccumulatedLosses 2023-03-31 05039242 core:PreviouslyStatedAmount 2023-03-31 05039242 core:PreviouslyStatedAmount core:ShareCapital 2024-03-31 05039242 bus:Director1 2023-03-31 05039242 bus:Director1 2024-03-31 05039242 bus:Director2 2023-03-31 05039242 bus:Director2 2024-03-31 05039242 bus:Director1 2022-03-31 05039242 bus:Director1 2023-03-31 05039242 bus:Director2 2022-03-31 05039242 bus:Director2 2023-03-31 05039242 bus:Director1 2022-04-01 2023-03-31 05039242 bus:Director2 2022-04-01 2023-03-31 05039242 bus:SmallEntities 2023-04-01 2024-03-31 05039242 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 05039242 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 05039242 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 05039242 bus:AbridgedAccounts 2023-04-01 2024-03-31
Company registration number: 05039242
Romford & Ilford Family Chiropractic Limited
Unaudited filleted abridged financial statements
31 March 2024
Romford & Ilford Family Chiropractic Limited
Contents
Directors and other information
Accountants report
Abridged statement of financial position
Statement of changes in equity
Notes to the financial statements
Romford & Ilford Family Chiropractic Limited
Directors and other information
Directors Dr James Rowland Faulkner
Ms Aimee Faulkner
Secretary Ms Aimee Faulkner
Company number 05039242
Registered office 6th Floor AMP House
Dingwall Road
Croydon
CR0 2LX
Accountants Doshi & Co. Accountants
6th Floor AMP House
Dingwall Road
Croydon
CR0 2LX
Romford & Ilford Family Chiropractic Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Romford & Ilford Family Chiropractic Limited
Year ended 31 March 2024
As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 31 March 2024 which comprise the abridged statement of financial position, statement of changes in equity and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Doshi & Co. Accountants
6th Floor AMP House
Dingwall Road
Croydon
CR0 2LX
25 December 2024
Romford & Ilford Family Chiropractic Limited
Abridged statement of financial position
31 March 2024
2024 2023
Note £ £ £ £
Fixed assets
Tangible assets 5 28,262 32,324
_______ _______
28,262 32,324
Current assets
Debtors 255,679 138,842
Cash at bank and in hand 78,541 65,594
_______ _______
334,220 204,436
Creditors: amounts falling due
within one year ( 337,868) ( 201,555)
_______ _______
Net current (liabilities)/assets ( 3,648) 2,881
_______ _______
Total assets less current liabilities 24,614 35,205
Creditors: amounts falling due
after more than one year ( 23,274) ( 33,206)
_______ _______
Net assets 1,340 1,999
_______ _______
Capital and reserves
Called up share capital 110 110
Profit and loss account 1,230 1,889
_______ _______
Shareholders funds 1,340 1,999
_______ _______
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the current year ending 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.
These financial statements were approved by the board of directors and authorised for issue on 25 December 2024 , and are signed on behalf of the board by:
Dr James Rowland Faulkner
Director
Company registration number: 05039242
Romford & Ilford Family Chiropractic Limited
Statement of changes in equity
Year ended 31 March 2024
Called up share capital Profit and loss account Total
£ £ £
At 1 April 2022 (as previously reported) 100 1,335 1,435
Effects of changes in accounting policies 10 (-) 10
_______ _______ _______
At 1 April 2022 (restated) 110 1,335 1,445
Profit for the year 45,554 45,554
_______ _______ _______
Total comprehensive income for the year - 45,554 45,554
Dividends paid and payable ( 45,000) ( 45,000)
_______ _______ _______
Total investments by and distributions to owners - ( 45,000) ( 45,000)
At 31 March 2023 (as previously reported) 100 1,889 1,989
Effects of changes in accounting policies 10 - 10
_______ _______ _______
At 31 March 2023 (restated) and 1 April 2023 110 1,889 1,999
Profit for the year 34,341 34,341
_______ _______ _______
Total comprehensive income for the year - 34,341 34,341
Dividends paid and payable ( 35,000) ( 35,000)
_______ _______ _______
Total investments by and distributions to owners - ( 35,000) ( 35,000)
_______ _______ _______
At 31 March 2024 110 1,230 1,340
_______ _______ _______
Romford & Ilford Family Chiropractic Limited
Notes to the financial statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 6th Floor AMP House, Dingwall Road, Croydon, CR0 2LX.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 12 (2023: 11 ).
5. Tangible assets
£
Cost
At 1 April 2023 179,104
Additions 3,725
_______
At 31 March 2024 182,829
_______
Depreciation
At 1 April 2023 146,780
Charge for the year 7,787
_______
At 31 March 2024 154,567
_______
Carrying amount
At 31 March 2024 28,262
_______
At 31 March 2023 32,324
_______
6. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2024
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Dr James Rowland Faulkner 17,294 67,289 ( 32,020) 52,563
Ms Aimee Faulkner 86,938 95,134 ( 43,049) 139,023
_______ _______ _______ _______
104,232 162,423 ( 75,069) 191,586
_______ _______ _______ _______
2023
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Dr James Rowland Faulkner ( 263) - 17,557 17,294
Ms Aimee Faulkner 52,496 - 34,442 86,938
_______ _______ _______ _______
52,233 - 51,999 104,232
_______ _______ _______ _______
7. Controlling party
The Company is controlled by sole director Dr J Faulkner, who controls the company by virtue of his 51% Shareholdings.
8. Loans to Aimee Sawers (Wife)
During the year, the company has given loan of £139,023 to Aimee Sawers (wife) who is a director and holding 49% shares in the company. Amount due from Aimee Sawers as at 31.03.24 was £139,023 (2023: £86,938).